Garmendia Madariaga A, Santos Palacios S, Guillen-Grima F, Galofre JC. The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J Clin Endocrinol Metab. 2014;99:923–31.CrossrefPubMedWeb of ScienceGoogle Scholar
Yang R, Yao L, Fang Y, Sun J, Guo T, Yang K, et al. The relationship between subclinical thyroid dysfunction and the risk of fracture or low bone mineral density: a systematic review and meta-analysis of cohort studies. J Bone Miner Metab. 2018;36:209–20.Web of SciencePubMedCrossrefGoogle Scholar
Harvey CB, O’Shea PJ, Scott AJ, Robson H, Siebler T, Shalet SM, et al. Molecular mechanisms of thyroid hormone effects on bone growth and function. Mol Genet Metab. 2002;75:17–30.CrossrefGoogle Scholar
Tsourdi E, Rijntjes E, Kohrle J, Hofbauer LC, Rauner M. Hyperthyroidism and hypothyroidism in male mice and their effects on bone mass, bone turnover, and the Wnt inhibitors sclerostin and Dickkopf-1. Endocrinology. 2015;156:3517–27.CrossrefWeb of ScienceGoogle Scholar
Skowronska-Jozwiak E, Lewandowski KC, Adamczewski Z, Krawczyk-Rusiecka K, Lewinski A. Mechanisms of normalisation of bone metabolism during recovery from hyperthyroidism: potential role for sclerostin and parathyroid hormone. Int J Endocrinol. 2015;2015:948384.PubMedWeb of ScienceGoogle Scholar
Siru R, Alfonso H, Chubb SA, Golledge J, Flicker L, Yeap BB. Subclinical thyroid dysfunction and circulating thyroid hormones are not associated with bone turnover markers or incident hip fracture in older men. Clin Endocrinol (Oxf). 2018;89:93–9.CrossrefPubMedGoogle Scholar
Sekeroglu MR, Altun ZB, Algun E, Dulger H, Noyan T, Balaharoglu R, et al. Serum cytokines and bone metabolism in patients with thyroid dysfunction. Adv Ther. 2006;23:475–80.CrossrefPubMedGoogle Scholar
Alhazidou E, Pergialiotis V, Panagopoulos P, Chrelias C, Hatziagelaki E, Papantoniou N, et al. The impact of the metabolic syndrome on bone mass density: a prospective case control study. Horm Mol Biol Clin Investig. 2017;33. Article ID: 20170053.Web of ScienceGoogle Scholar
Mohammadi B, Haghpanah V, Tavangar SM, Larijani B. Modeling the effect of levothyroxine therapy on bone mass density in postmenopausal women: a different approach leads to new inference. Theor Biol Med Model. 2007;4:23.CrossrefWeb of ScienceGoogle Scholar
Polovina SP, Miljic D, Zivojinovic S, Milic N, Micic D, Brkic VP. The impact of thyroid autoimmunity (TPOAb) on bone density and fracture risk in postmenopausal women. Hormones (Athens). 2017;16:54–61.Google Scholar
Çamurdan Orhun M, Döğer E, Bideci A, Çelik N, Cinaz P. Vitamin D status in children with Hashimoto thyroiditis. J Ped Endocrinol Metab. 2012;25:467–70.Google Scholar
Segna D, Bauer DC, Feller M, Schneider C, Fink HA, Aubert CE, et al. Association between subclinical thyroid dysfunction and change in bone mineral density in prospective cohorts. J Intern Med. 2018;283:56–72.PubMedCrossrefWeb of ScienceGoogle Scholar
About the article
Published Online: 2018-09-18
Research funding: The authors report that they did not receive funding for the present study.
Conflict of interest: Authors state no conflict of interest.
Informed consent: All participants provided informed consent prior to their inclusion.
Ethical approval: The research related to human use complied with all the relevant national regulations and institutional policies and was performed in accordance to the tenets of the Declaration of Helsinki and has been approved by the Institutional Review Board of the authors hospital.